Skip to content

Will a Lidocaine Patch Fail a Drug Test? Fact vs. Fiction in Pharmacology

4 min read

According to a 2019 study published in the journal Clinical Toxicology, there was no evidence that lidocaine or its metabolites produced false positive results for cocaine on standard urine immunoassays. Dispelling a common misconception, a lidocaine patch is highly unlikely to cause you to fail a drug test for illicit substances like cocaine.

Quick Summary

It is unlikely for a lidocaine patch to cause a failed drug test for common drugs of abuse. While initial immunoassays might rarely produce a false positive result due to cross-reactivity, confirmatory tests reliably differentiate between lidocaine and illicit substances.

Key Points

  • No Failed Drug Test: A lidocaine patch is highly unlikely to cause a failed drug test for common drugs of abuse, including cocaine, based on scientific evidence.

  • False Positive Rarity: Any initial false positive result on a less specific immunoassay screen is very rare and is reliably overturned by more advanced confirmatory testing.

  • Confirmatory Test Accuracy: Confirmatory tests like GC-MS and LC-MS can accurately distinguish between lidocaine and its metabolites from illicit substances based on their unique molecular structures.

  • Lidocaine vs. Cocaine: Although both are local anesthetics, their chemical structures and metabolic pathways are different, which is why drug tests can tell them apart.

  • Documentation is Key: In case of a rare false positive, disclosing your use of the lidocaine patch and providing prescription documentation to a Medical Review Officer will clarify the situation.

  • Non-Controlled Substance: Lidocaine is a non-narcotic, non-addictive local anesthetic and is not a controlled substance, meaning it is not the target of standard drug screenings.

  • Informing the Tester: Always inform the drug testing personnel about any medications you are taking, whether prescribed or over-the-counter, to avoid misunderstandings.

In This Article

Understanding Drug Testing and the Lidocaine Patch

Concerns about whether a lidocaine patch could cause a failed drug test are common, but they are largely based on misconception. The key to understanding why this is not a significant risk lies in knowing how drug tests work and the specific pharmacology of lidocaine. Most workplace or standard drug screens are designed to detect common illicit substances, and they operate in a two-stage process: an initial screening test (immunoassay) and a confirmatory test (often gas chromatography-mass spectrometry, or GC-MS).

The Two-Step Drug Testing Process

  1. Initial Immunoassay Screen: The first line of defense in drug testing uses an immunoassay, which is a rapid, cost-effective test that relies on antibodies to detect specific drug classes or metabolites. Because this test is designed to be highly sensitive and broad, it can sometimes produce a false positive result for a legal substance that shares a similar chemical structure with a targeted illegal drug. In the past, and sometimes based on anecdotal reports, it was speculated that lidocaine could be mistaken for cocaine on these initial screens due to some structural resemblance.
  2. Confirmatory GC-MS Test: If the initial immunoassay screen returns a positive result, a second, more specific and expensive test is performed to confirm the finding. This is where substances like lidocaine are reliably distinguished from illicit drugs. GC-MS is a highly advanced technique that separates and identifies individual chemical components in a sample based on their unique molecular structure. This process makes it virtually impossible to confuse a prescription medication with an illegal substance.

The Pharmacological Difference: Lidocaine vs. Cocaine

While both lidocaine and cocaine are local anesthetics, their chemical structures and metabolic pathways are fundamentally different, which is why a properly conducted drug test can tell them apart.

  • Lidocaine is an amide-type local anesthetic. It works by blocking voltage-gated sodium channels in nerve membranes, preventing the initiation and conduction of nerve impulses. It is metabolized primarily in the liver by the cytochrome P450 (CYP450) enzymes, mainly CYP1A2 and CYP3A4, into inactive metabolites such as monoethylglycinexylidide (MEGX).
  • Cocaine is a tropane alkaloid, and its metabolism is distinct. It is primarily broken down into the metabolites benzoylecgonine (BE) and ecgonine methyl ester. Drug tests for cocaine specifically look for these metabolites, not the parent drug, to confirm recent use.

Because lidocaine's metabolites (like MEGX) are different from cocaine's metabolites (like BE), the confirmatory GC-MS test can clearly differentiate between them.

What if a False Positive Occurs?

If you receive a false positive result from an initial immunoassay while using a lidocaine patch, it's crucial to take specific steps to rectify the situation. The process for managing a false positive typically involves:

  • Disclosing Your Medication: Inform the testing authority, such as your employer's Medical Review Officer (MRO), that you are using a prescribed or over-the-counter lidocaine product. This transparency can preemptively clarify the situation.
  • Requesting Confirmatory Testing: Insist on a confirmatory GC-MS or LC-MS test. This is the definitive step that will provide an accurate result and exonerate you from any false accusations.
  • Providing Prescription Documentation: If applicable, provide documentation from your healthcare provider detailing your prescription and the medical necessity for the lidocaine patch.

Comparison of Testing Methods

Feature Initial Immunoassay Screen Confirmatory GC-MS/LC-MS Test
Purpose Rapid, presumptive testing for drug classes. Definitive identification of specific drugs and metabolites.
Detection Broad detection based on antibody binding; high sensitivity. Precise identification based on molecular structure; high specificity.
Cost Generally lower cost per test. Higher cost per test due to advanced technology.
False Positives Possible due to cross-reactivity with structurally similar substances. Extremely rare; considered the gold standard for accuracy.
Lidocaine Impact May cause rare false positive for cocaine in some older tests. Accurately distinguishes lidocaine metabolites (MEGX) from cocaine metabolites (BE).
Reliability Screening tool; requires confirmation for positive results. Confirmatory tool; provides legally and medically valid results.

Scientific Evidence and Clinical Consensus

Scientific studies have repeatedly concluded that lidocaine does not cause false positives for cocaine on standard urine drug screens. For example, a 2019 study in Clinical Toxicology found zero false positives for cocaine among subjects who were exposed to therapeutic lidocaine. The study tested both lidocaine and its primary metabolite, norlidocaine (MEGX), and found no cross-reactivity with cocaine immunoassays.

Lidocaine: A Non-Controlled Substance

It is also important to remember that lidocaine is not a controlled substance or narcotic, further reducing the likelihood of a failed drug test. It is a local anesthetic that works on a localized area of the body and does not produce a psychoactive effect. A prescription is often required for higher-strength patches, but the medication itself is not subject to the same regulatory scrutiny as controlled substances.

Conclusion

While the prospect of a false positive result from a routine drug screen can be unsettling, rest assured that using a lidocaine patch will not cause you to fail a drug test. The risk of a false positive on an initial immunoassay is extremely low, and any positive result would be definitively cleared by confirmatory testing using advanced methods like GC-MS. The pharmacological differences between lidocaine and illicit drugs ensure that an accurate analysis can be made. For peace of mind, always disclose your use of any prescribed or over-the-counter medications to the testing administrator and have your prescription information readily available.

Frequently Asked Questions

Studies have found no evidence that lidocaine or its metabolites, like monoethylglycinexylidide (MEGX), cause false positives for the cocaine metabolite benzoylecgonine (BE) on standard urine immunoassays.

An immunoassay is a quick, initial screening test that can sometimes have cross-reactivity with other substances, potentially causing false positives. A GC-MS (gas chromatography-mass spectrometry) test is a highly accurate, second-stage test used to confirm a positive screen result and reliably identifies the exact chemical compound.

If you receive an initial positive result, inform the Medical Review Officer (MRO) immediately that you are using a lidocaine patch and request a confirmatory GC-MS test. This advanced test will differentiate between lidocaine and illicit drugs.

No, lidocaine is a local anesthetic and is not classified as a narcotic or a controlled substance. It does not have addictive properties and is not a drug of abuse.

Standard hair follicle drug tests, which typically screen for substances like opioids, cocaine, and amphetamines, are not designed to detect lidocaine. False positives from lidocaine are not a recognized issue with this testing method.

Just like prescription-strength lidocaine, over-the-counter lidocaine patches or gels are not expected to cause false positive results for illicit drugs. The same scientific principles regarding chemical differences and confirmatory testing apply.

Many common over-the-counter medications and even some foods can trigger false positives, such as ibuprofen for THC, certain cold medicines for amphetamines, and poppy seeds for opiates. However, lidocaine is not on this list for typical screening panels.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.